Congenital Heart Defects

Clinical Trial Finder

Many patients with congenital heart defects are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Remote Preconditioning and Myocardial Protection

Condition:   Congenital Heart Disease
Interventions:   Drug: Sevoflurane;   Drug: Sevoflurane plus remote ischemic preconditioning;   Drug: Total intravenous anesthesia
Sponsor:   Assiut University
Not yet recruiting - verified August 2016

Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology

Condition:   Congenital Heart Defect
Interventions:   Other: Human Milk Derived Fortifier;   Other: Human/Bovine Milk
Sponsors:   The University of Texas Health Science Center at San Antonio;   Prolacta Bioscience;   Texas Children's Hospital;   Children's Hospital of Philadelphia;   Children's Hospital Medical Center, Cincinnati;   Columbia University;   Emory University;   University of Oklahoma;   Ann & Robert H Lurie Children's Hospital of Chicago;   Cook Children's Medical Center
Recruiting - verified August 2016

The Human Trisome Project Biobank

Conditions:   Down Syndrome;   Trisomy 21
Intervention:  
Sponsor:   University of Colorado, Denver
Recruiting - verified August 2016

Near Infrared Spectroscopy in Cyanotic Congenital Heart Disease

Condition:   Congenital Heart Defects
Intervention:  
Sponsors:   KK Women's and Children's Hospital;   Covidien Private Limited
Active, not recruiting - verified August 2016

Non Syndromic Congenital Heart Defect and Array-CGH in Prenatal Diagnosis

Condition:   Non Syndromic Congenital Heart
Intervention:  
Sponsor:   Rennes University Hospital
Recruiting - verified August 2016

Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?

Condition:   Congenital Heart Defects
Interventions:   Drug: Levosimendan;   Drug: Milrinone
Sponsors:   Göteborg University;   Helsinki University Central Hospital
Recruiting - verified August 2016

Examining Developmental Changes in Heart Contractions of Children With Congenital Heart Defects

Conditions:   Hypoplastic Left Heart Syndrome;   Tetralogy of Fallot
Intervention:  
Sponsors:   Emory University;   National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified August 2016

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points